Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels

Saved in:
Bibliographic Details
Published in:Haematologica (Roma) 2020-01, Vol.105 (1), p.e22-e25
Main Authors: Lujan, Juliana Velez, Lengerke-Diaz, Paula A, Jacobs, Chaja, Moreno-Cortes, Eider F, Ramirez-Segura, Cesar A, Choi, Michael Y, McCarthy, Colin, Heinen, Alaina, Kipps, Thomas J, Castro, Januario E
Format: Article
Language:English
Subjects:
Adenine - analogs & derivatives
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Cytokines
Humans
Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy
Online Only
Piperidines
Plasma
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.2018.212597